Target intelligence / Profile preview

GPI-anchor transamidase catalytic subunit (PIGK) (PIGK)

Target
PIGK
Molecular classification
Enzyme (cysteine protease, C13 family), Component of the GPI transamidase complex, Membrane-associated protein
01

Overview

GPI-anchor transamidase catalytic subunit (PIGK) is a cysteine protease enzyme (C13 family) and the catalytic component of the multi-subunit GPI transamidase complex that is located in the endoplasmic reticulum membrane[1][2][3][4]. This enzyme catalyzes the transfer of a glycosylphosphatidylinositol (GPI) anchor to proteins, specifically by cleaving their C-terminal signal peptide and attaching the pre-assembled GPI anchor, a glycolipid that tethers many proteins to the cell surface[1][2][3][4]. GPI-anchored proteins are important in various biological functions including enzymatic activity, signaling, cell adhesion, and immune regulation[1][2]. PIGK functions via a caspase/legumain-like cysteine protease mechanism[1][2]. It interacts with other complex subunits (e.g., PIGT, GPAA1, PIGU, and PIGS)[2][4], and mutations have been linked to severe neurological disorders and potentially contribute to certain cancers[2][3]. PIGK is essential for normal GPI-anchor biosynthesis; deficiency leads to broad post-translational modification defects with clinical consequences[3]. Currently, no drugs are known to target PIGK directly, and it is not established as a therapeutic target, but its centrality in GPI-anchor biosynthesis and disease association make it of expanding biomedical interest[3][4].

Other names
GPI8hGPI8PIG-Kphosphatidylinositol glycan anchor biosynthesis class KGPI-anchor transamidase component PIGKGPI8 homologNEDHCAS
02

Biological functions

GPI-anchor biosynthesisPost-translational protein modification (GPI-anchoring)Protein processing in endoplasmic reticulum
03

Disease associations

Neurodevelopmental disorder with or without hypotonia, seizures, and cerebellar atrophy (NEDHCAS)Cancer (as implicated through aberrant activity)Other disorders related to GPI-anchor deficiency
04

Safety considerations

Loss of function associated with neurodevelopmental disorders, epilepsy, and cerebellar atrophyLoss or alteration may result in widespread cell surface protein targeting defects, as many proteins rely on GPI-anchoring

Beyond the preview

Go deeper on GPI-anchor transamidase catalytic subunit (PIGK) (PIGK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GPI-anchor transamidase catalytic subunit (PIGK) (PIGK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call